Valuation: Celltrion, Inc.

Market Cap 44,100B 31.84B 27.25B 25.49B 23.33B 43.79B 3,044B 44.36B 301B 117B 1,529B 119B 117B 5,072B P/E 2026 *
29.2x
P/E 2027 * 25.3x
Enterprise Value 46.3B 33.43M 28.61M 26.76M 24.49M 45.97M 3.2B 46.58M 316M 123M 1.61B 125M 123M 5.33B EV / Sales 2026 *
8.45x
EV / Sales 2027 * 7.23x
Free-Float
60.59%
Yield 2026 *
0.39%
Yield 2027 * 0.43%
1 day-0.93%
1 week-4.33%
Current month+3.00%
1 month+13.05%
3 months+1.62%
6 months-16.56%
Current year+11.56%
1 week 187,600
Extreme 187600
202,000
1 month 170,800
Extreme 170800
212,000
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 114,250.83
Extreme 114250.828535
239,047.62
5 years 114,250.83
Extreme 114250.828535
247,058.06
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 20/03/2015
Chief Executive Officer 42 26/03/2021
President 50 13/02/2026
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 01/04/2005
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap.
16/1/26 Sell 500 0.0002%
16/1/26 Sell 1,000 0.0004%
16/1/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.93%-4.33%+16.18%+53.76% 31.82B
+1.09%+5.26%+4.52%+26.24% 51.61B
-1.07%+2.82%+465.96%+586.75% 44.89B
+1.47%+9.79%+35.92%+21.40% 42.77B
+1.44%+7.77%+19.38%+92.75% 42.58B
+1.32%+7.30%+33.89%+150.10% 17.33B
-0.60%+1.93% - - 16.63B
+0.03%+3.41%+6.55%+32.10% 14.76B
+1.28%+5.41%+82.40%+47.43% 14.09B
-1.17%+5.57%-2.05%-31.15% 13.29B
Average +0.29%+4.55%+73.64%+108.82% 28.98B
Weighted average by Cap. +0.41%+4.76%+94.63%+137.66%

Financials

2026 *2027 *
Net sales 5,480B 3.96B 3.39B 3.17B 2.9B 5.44B 378B 5.51B 37.43B 14.58B 190B 14.85B 14.52B 630B 6,294B 4.54B 3.89B 3.64B 3.33B 6.25B 434B 6.33B 42.99B 16.75B 218B 17.05B 16.68B 724B
Net income 1,511B 1.09B 934M 873M 799M 1.5B 104B 1.52B 10.32B 4.02B 52.38B 4.09B 4B 174B 1,763B 1.27B 1.09B 1.02B 933M 1.75B 122B 1.77B 12.04B 4.69B 61.14B 4.78B 4.67B 203B
Net Debt 2,199B 1.59B 1.36B 1.27B 1.16B 2.18B 152B 2.21B 15.02B 5.85B 76.23B 5.96B 5.83B 253B 1,409B 1.02B 871M 814M 745M 1.4B 97.27B 1.42B 9.62B 3.75B 48.85B 3.82B 3.73B 162B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,680
Date Price Change Volume
21/08/26 ₩192,300.00 -0.93% 354,956
20/08/26 ₩194,100.00 0.00% 484,272
19/08/26 ₩194,100.00 -0.72% 375,772
18/08/26 ₩195,500.00 -2.74% 600,291
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
192,300.00KRW
Average target price
266,031.64KRW
Spread / Average Target
+38.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock